Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iris Energy Limited (IREN) vs Revvity Inc (RVTY) Price & Performance

Iris Energy LimitedTrade
Revvity IncTrade

Price performance (Past 24H)

Key statistics

Iris Energy Limited vs Revvity Inc — how do they compare? Iris Energy Limited trades at $35.27 (market cap $14.07B), while Revvity Inc trades at $154.1 (market cap $16.98B). The key difference: Revvity Inc is the larger of the two by market cap, and Revvity Inc pays a 0.18% dividend while Iris Energy Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iris Energy Limited for 28 Days and Revvity Inc for 12 Days on average.

IRENRVTY
Market Cap
$14.07B$16.98B
Volume
54,492,4601,456,900
Sector
TechnologyHealth
52-Week High
$76.41$157.36
52-Week Low
$29.31$82.26
Typical Hold Time
28 Days12 Days
Enterprise Value
$16.02B$19.30B
Dividend Yield
—0.18%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Iris Energy Limited

IREN shares are trading at $35.19, down 9.05% in the last 24 hours, reflecting ongoing investor concerns despite strong analyst optimism. The stock shows bearish technical signals with key support at $33, while fundamental metrics reveal a challenging profitability picture with a negative net income margin of -99.38% despite revenue growth projections. Recent news highlights the company's aggressive pivot from Bitcoin mining to AI infrastructure, backed by multi-billion dollar contracts with Microsoft and NVIDIA.

The investment case hinges on execution of IREN's ambitious AI infrastructure expansion, with JPMorgan projecting $24 billion in annual revenue by 2030. However, significant risks include ballooning losses, high capital expenditure requirements, and intense competition in the neocloud space. Despite 80% analyst buy ratings and an $81 consensus price target suggesting 130% upside, the stock faces near-term pressure from missed earnings and negative cash flow trends.

Revvity Inc

RVTY trades at $155.01, up 0.92% with a bullish technical outlook. The stock shows strong earnings momentum with three consecutive quarterly beats and maintains solid profitability with 54.98% gross margins. Recent developments include new product launches in Europe and strategic acquisitions to expand metabolic disease research capabilities.

The investment case balances premium valuation (P/E 73.15) against consistent execution and growth initiatives. Key risks include China market pressures and margin compression, while analyst consensus remains positive with 52% buy ratings. Upside potential exists if Q3 earnings meet expectations in November.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

IREN
81% Buy19% Sell
Avg holding period · 28 Days
RVTY
0% Buy100% Sell
Avg holding period · 12 Days

Top news

Latest headlines on both assets

About Iris Energy Limited

Iris Energy is a next-generation data center company that powers Bitcoin mining and AI workloads using 100% renewable energy. It focuses on building sustainable infrastructure for the global digital economy.

Read more on IREN →

About Revvity Inc

Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.

Read more on RVTY →